Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800)

Fitriyadi Kusuma; Glenardi Glenardi; Ghea Mangkuliguna; Hariyono Winarto; Gatot Purwoto; Tofan Widya Utami; Tricia Dewi Anggraeni

doi:10.1371/journal.pone.0316871

Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800)

Fitriyadi Kusuma, Glenardi Glenardi, Ghea Mangkuliguna, Hariyono Winarto, Gatot Purwoto, Tofan Widya Utami, Tricia Dewi Anggraeni

Department of Obstetrics and Gynecology Clinic

Research output: Contribution to journal › Comment/debate

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0307800.].

Original language	English
Pages (from-to)	e0316871
Journal	PloS one
Volume	19
Issue number	12
DOIs	https://doi.org/10.1371/journal.pone.0316871
Publication status	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0316871

Fingerprint

Dive into the research topics of 'Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800)'. Together they form a unique fingerprint.

Cite this

Kusuma, F., Glenardi, G., Mangkuliguna, G., Winarto, H., Purwoto, G., Utami, T. W., & Anggraeni, T. D. (2024). Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800). PloS one, 19(12), e0316871. https://doi.org/10.1371/journal.pone.0316871

Kusuma, Fitriyadi ; Glenardi, Glenardi ; Mangkuliguna, Ghea et al. / Erratum : Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800). In: PloS one. 2024 ; Vol. 19, No. 12. pp. e0316871.

@article{103a049e2ff9474ca0f48dd74d6c897c,

title = "Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800)",

abstract = "[This corrects the article DOI: 10.1371/journal.pone.0307800.].",

author = "Fitriyadi Kusuma and Glenardi Glenardi and Ghea Mangkuliguna and Hariyono Winarto and Gatot Purwoto and Utami, {Tofan Widya} and Anggraeni, {Tricia Dewi}",

note = "Publisher Copyright: Copyright: {\textcopyright} 2024 Kusuma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2024",

doi = "10.1371/journal.pone.0316871",

language = "English",

volume = "19",

pages = "e0316871",

journal = "PloS one",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "12",

}

Kusuma, F, Glenardi, G, Mangkuliguna, G, Winarto, H , Purwoto, G , Utami, TW & Anggraeni, TD 2024, 'Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800)', PloS one, vol. 19, no. 12, pp. e0316871. https://doi.org/10.1371/journal.pone.0316871

Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800). / Kusuma, Fitriyadi; Glenardi, Glenardi; Mangkuliguna, Ghea et al.
In: PloS one, Vol. 19, No. 12, 2024, p. e0316871.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800)

AU - Kusuma, Fitriyadi

AU - Glenardi, Glenardi

AU - Mangkuliguna, Ghea

AU - Winarto, Hariyono

AU - Purwoto, Gatot

AU - Utami, Tofan Widya

AU - Anggraeni, Tricia Dewi

N1 - Publisher Copyright: Copyright: © 2024 Kusuma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2024

Y1 - 2024

N2 - [This corrects the article DOI: 10.1371/journal.pone.0307800.].

AB - [This corrects the article DOI: 10.1371/journal.pone.0307800.].

UR - http://www.scopus.com/inward/record.url?scp=85215065390&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0316871

DO - 10.1371/journal.pone.0316871

M3 - Comment/debate

C2 - 39775309

AN - SCOPUS:85215065390

SN - 1932-6203

VL - 19

SP - e0316871

JO - PloS one

JF - PloS one

IS - 12

ER -

Kusuma F, Glenardi G, Mangkuliguna G, Winarto H , Purwoto G , Utami TW et al. Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800). PloS one. 2024;19(12):e0316871. doi: 10.1371/journal.pone.0316871

Erratum: Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials (PloS one (2024) 19 8 DOI: 10.1371/journal.pone.0307800)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this